Skip to content

Irisin Is Associated with Functional Outcomes in the Ischemic Stroke

Irisin Is Associated with Functional Outcomes in the Ischemic Stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OPC-17013501
Enrollment
Unknown
Registered
2017-11-23
Start date
2017-12-16
Completion date
Unknown
Last updated
2017-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Stroke

Interventions

Patients with Ischemic Stroke:No

Sponsors

Affiliated Hospital of Weifang Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 90 Years

Inclusion criteria

Inclusion criteria: AIS was defined according to the World Health Organization Multinational Monitoring of Trends and Determinants in Cardiovascular Disease (WHO-MONICA) criteria, and were verified by magnetic resonance imaging (MRI) reports performed within 24hours after admission.

Exclusion criteria

Exclusion criteria: (1) pre-stroke diagnosis of dementia or cognitive impairment, a history of any psychiatric illness and decreased level of consciousness; (2) malignant tumor, sarcopenia, liver insufficiency and renal insufficiency (creatinine >1.5 mg/dl), metabolic abnormalities (not included diabetes), severe edema and autoimmune diseases; (3) used psychotropic drugs prior to stroke onset; (4) without informed consents, lost blood samples, or current medications used that influence serum irisin levels.

Design outcomes

Primary

MeasureTime frame
modified Rankin Scale;

Secondary

MeasureTime frame
NIHSS score;

Countries

China

Contacts

Public ContactXian-Wei Zeng

Affiliated Hospital of Weifang Medical College

wfzwxin@126.com+86 15201338315

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 6, 2026